| BCR Batch | Study Abbreviation | Study Name | BCR |
|---|---|---|---|
| 0 | CNTL | Controls | NCH |
| 1 | GBM | Glioblastoma multiforme | NCH |
| 2 | GBM | Glioblastoma multiforme | NCH |
| 3 | GBM | Glioblastoma multiforme | NCH |
| 4 | GBM | Glioblastoma multiforme | NCH |
| 5 | GBM | Glioblastoma multiforme | NCH |
| 6 | GBM | Glioblastoma multiforme | NCH |
| 7 | GBM | Glioblastoma multiforme | NCH |
| 8 | GBM | Glioblastoma multiforme | NCH |
| 9 | OV | Ovarian serous cystadenocarcinoma | NCH |
| 10 | GBM | Glioblastoma multiforme | NCH |
| 11 | OV | Ovarian serous cystadenocarcinoma | NCH |
| 12 | OV | Ovarian serous cystadenocarcinoma | NCH |
| 13 | OV | Ovarian serous cystadenocarcinoma | NCH |
| 14 | OV | Ovarian serous cystadenocarcinoma | NCH |
| 15 | OV | Ovarian serous cystadenocarcinoma | NCH |
| 16 | GBM | Glioblastoma multiforme | NCH |
| 17 | OV | Ovarian serous cystadenocarcinoma | NCH |
| 18 | OV | Ovarian serous cystadenocarcinoma | NCH |
| 19 | OV | Ovarian serous cystadenocarcinoma | NCH |
| 20 | GBM | Glioblastoma multiforme | NCH |
| 21 | OV | Ovarian serous cystadenocarcinoma | NCH |
| 22 | OV | Ovarian serous cystadenocarcinoma | NCH |
| 23 | LUSC | Lung squamous cell carcinoma | NCH |
| 24 | OV | Ovarian serous cystadenocarcinoma | NCH |
| 25 | LAML | Acute Myeloid Leukemia | WUSM |
| 26 | GBM | Glioblastoma multiforme | NCH |
| 27 | OV | Ovarian serous cystadenocarcinoma | NCH |
| 28 | COAD | Colon adenocarcinoma | NCH |
| 29 | COAD | Colon adenocarcinoma | NCH |
| 30 | COAD | Colon adenocarcinoma | NCH |
| 31 | LUSC | Lung squamous cell carcinoma | NCH |
| 32 | KIRC | Kidney renal clear cell carcinoma | NCH |
| 33 | COAD | Colon adenocarcinoma | NCH |
| 34 | LUAD | Lung adenocarcinoma | WUSM |
| 35 | COAD | Colon adenocarcinoma | NCH |
| 36 | COAD | Colon adenocarcinoma | NCH |
| 37 | LUAD | Lung adenocarcinoma | NCH |
| 38 | GBM | Glioblastoma multiforme | NCH |
| 39 | LUSC | Lung squamous cell carcinoma | NCH |
| 40 | OV | Ovarian serous cystadenocarcinoma | NCH |
| 41 | COAD | Colon adenocarcinoma | NCH |
| 42 | READ | Rectum adenocarcinoma | NCH |
| 43 | READ | Rectum adenocarcinoma | NCH |
| 44 | OV | Ovarian serous cystadenocarcinoma | NCH |
| 45 | COAD | Colon adenocarcinoma | NCH |
| 46 | READ | Rectum adenocarcinoma | NCH |
| 47 | BRCA | Breast invasive carcinoma | NCH |
| 48 | STAD | Stomach adenocarcinoma | NCH |
| 49 | UCEC | Uterine Corpus Endometrial Carcinoma | NCH |
| 50 | KIRC | Kidney renal clear cell carcinoma | NCH |
| 51 | KIRP | Kidney renal papillary cell carcinoma | NCH |
| 52 | LUAD | Lung adenocarcinoma | NCH |
| 53 | LUSC | Lung squamous cell carcinoma | NCH |
| 54 | HNSC | Head and Neck squamous cell carcinoma | NCH |
| 55 | LIHC | Liver hepatocellular carcinoma | NCH |
| 56 | BRCA | Breast invasive carcinoma | NCH |
| 57 | STAD | Stomach adenocarcinoma | NCH |
| 58 | LUAD | Lung adenocarcinoma | NCH |
| 59 | UCEC | Uterine Corpus Endometrial Carcinoma | NCH |
| 60 | LUSC | Lung squamous cell carcinoma | NCH |
| 61 | BRCA | Breast invasive carcinoma | NCH |
| 62 | GBM | Glioblastoma multiforme | NCH |
| 63 | KIRC | Kidney renal clear cell carcinoma | NCH |
| 64 | KIRC | Kidney renal clear cell carcinoma | NCH |
| 65 | KIRC | Kidney renal clear cell carcinoma | NCH |
| 66 | COAD | Colon adenocarcinoma | NCH |
| 67 | READ | Rectum adenocarcinoma | NCH |
| 68 | KIRC | Kidney renal clear cell carcinoma | NCH |
| 69 | KIRC | Kidney renal clear cell carcinoma | NCH |
| 70 | KIRC | Kidney renal clear cell carcinoma | NCH |
| 71 | KIRP | Kidney renal papillary cell carcinoma | NCH |
| 72 | BRCA | Breast invasive carcinoma | NCH |
| 73 | UCEC | Uterine Corpus Endometrial Carcinoma | NCH |
| 74 | BRCA | Breast invasive carcinoma | NCH |
| 75 | UCEC | Uterine Corpus Endometrial Carcinoma | NCH |
| 76 | COAD | Colon adenocarcinoma | NCH |
| 77 | LUSC | Lung squamous cell carcinoma | NCH |
| 78 | LGG | Brain Lower Grade Glioma | NCH |
| 79 | GBM | Glioblastoma multiforme | NCH |
| 80 | BRCA | Breast invasive carcinoma | NCH |
| 81 | UCEC | Uterine Corpus Endometrial Carcinoma | NCH |
| 82 | KIRC | Kidney renal clear cell carcinoma | NCH |
| 83 | HNSC | Head and Neck squamous cell carcinoma | NCH |
| 84 | LUAD | Lung adenocarcinoma | NCH |
| 85 | BRCA | Breast invasive carcinoma | NCH |
| 86 | BLCA | Bladder Urothelial Carcinoma | NCH |
| 87 | THCA | Thyroid carcinoma | NCH |
| 88 | CESC | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
| 89 | COAD | Colon adenocarcinoma | NCH |
| 90 | KIRC | Kidney renal clear cell carcinoma | NCH |
| 91 | PRAD | Prostate adenocarcinoma | NCH |
| 92 | UCEC | Uterine Corpus Endometrial Carcinoma | NCH |
| 93 | BRCA | Breast invasive carcinoma | NCH |
| 94 | UCEC | Uterine Corpus Endometrial Carcinoma | NCH |
| 95 | STAD | Stomach adenocarcinoma | NCH |
| 96 | BRCA | Breast invasive carcinoma | NCH |
| 97 | UCEC | Uterine Corpus Endometrial Carcinoma | NCH |
| 98 | COAD | Colon adenocarcinoma | NCH |
| 99 | READ | Rectum adenocarcinoma | NCH |
| 100 | LIHC | Liver hepatocellular carcinoma | NCH |
| 101 | LUSC | Lung squamous cell carcinoma | NCH |
| 102 | READ | Rectum adenocarcinoma | NCH |
| 103 | BRCA | Breast invasive carcinoma | NCH |
| 104 | UCEC | Uterine Corpus Endometrial Carcinoma | NCH |
| 105 | KIRC | Kidney renal clear cell carcinoma | NCH |
| 106 | PAAD | Pancreatic adenocarcinoma | NCH |
| 107 | HNSC | Head and Neck squamous cell carcinoma | NCH |
| 108 | PRAD | Prostate adenocarcinoma | NCH |
| 109 | BRCA | Breast invasive carcinoma | NCH |
| 110 | UCEC | Uterine Corpus Endometrial Carcinoma | NCH |
| 111 | GBM | Glioblastoma multiforme | NCH |
| 112 | LGG | Brain Lower Grade Glioma | NCH |
| 113 | BLCA | Bladder Urothelial Carcinoma | NCH |
| 114 | CESC | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
| 115 | THCA | Thyroid carcinoma | NCH |
| 116 | COAD | Colon adenocarcinoma | NCH |
| 117 | BRCA | Breast invasive carcinoma | NCH |
| 118 | UCEC | Uterine Corpus Endometrial Carcinoma | NCH |
| 119 | LUAD | Lung adenocarcinoma | NCH |
| 120 | BRCA | Breast invasive carcinoma | NCH |
| 121 | UCEC | Uterine Corpus Endometrial Carcinoma | NCH |
| 122 | READ | Rectum adenocarcinoma | NCH |
| 123 | COAD | Colon adenocarcinoma | NCH |
| 124 | BRCA | Breast invasive carcinoma | NCH |
| 125 | UCEC | Uterine Corpus Endometrial Carcinoma | NCH |
| 126 | THCA | Thyroid carcinoma | NCH |
| 127 | CESC | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
| 128 | BLCA | Bladder Urothelial Carcinoma | NCH |
| 129 | STAD | Stomach adenocarcinoma | NCH |
| 130 | GBM | Glioblastoma multiforme | NCH |
| 131 | LIHC | Liver hepatocellular carcinoma | NCH |
| 132 | COAD | Colon adenocarcinoma | NCH |
| 133 | READ | Rectum adenocarcinoma | NCH |
| 134 | PAAD | Pancreatic adenocarcinoma | NCH |
| 135 | DLBC | Lymphoid Neoplasm Diffuse Large B-cell Lymphoma | NCH |
| 136 | BRCA | Breast invasive carcinoma | NCH |
| 137 | UCEC | Uterine Corpus Endometrial Carcinoma | NCH |
| 138 | COAD | Colon adenocarcinoma | NCH |
| 139 | READ | Rectum adenocarcinoma | NCH |
| 140 | LUSC | Lung squamous cell carcinoma | NCH |
| 142 | BRCA | Breast invasive carcinoma | NCH |
| 143 | UCEC | Uterine Corpus Endometrial Carcinoma | NCH |
| 144 | LUAD | Lung adenocarcinoma | NCH |
| 145 | HNSC | Head and Neck squamous cell carcinoma | NCH |
| 146 | LGG | Brain Lower Grade Glioma | NCH |
| 147 | BRCA | Breast invasive carcinoma | NCH |
| 148 | CESC | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
| 149 | THCA | Thyroid carcinoma | NCH |
| 150 | BLCA | Bladder Urothelial Carcinoma | NCH |
| 151 | HNSC | Head and Neck squamous cell carcinoma | NCH |
| 152 | STAD | Stomach adenocarcinoma | NCH |
| 153 | LIHC | Liver hepatocellular carcinoma | NCH |
| 154 | COAD | Colon adenocarcinoma | NCH |
| 155 | BRCA | Breast invasive carcinoma | NCH |
| 156 | UCEC | Uterine Corpus Endometrial Carcinoma | NCH |
| 157 | COAD | Colon adenocarcinoma | NCH |
| 158 | READ | Rectum adenocarcinoma | NCH |
| 159 | LUSC | Lung squamous cell carcinoma | NCH |
| 160 | LUAD | Lung adenocarcinoma | NCH |
| 161 | PRAD | Prostate adenocarcinoma | NCH |
| 162 | KIRP | Kidney renal papillary cell carcinoma | NCH |
| 163 | LGG | Brain Lower Grade Glioma | NCH |
| 164 | HNSC | Head and Neck squamous cell carcinoma | NCH |
| 165 | STAD | Stomach adenocarcinoma | NCH |
| 166 | LUAD | Lung adenocarcinoma | NCH |
| 167 | BRCA | Breast invasive carcinoma | NCH |
| 168 | UCEC | Uterine Corpus Endometrial Carcinoma | NCH |
| 169 | CESC | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
| 170 | BLCA | Bladder Urothelial Carcinoma | NCH |
| 171 | THCA | Thyroid carcinoma | NCH |
| 172 | COAD | Colon adenocarcinoma | NCH |
| 173 | LIHC | Liver hepatocellular carcinoma | NCH |
| 174 | GBM | Glioblastoma multiforme | NCH |
| 175 | BLCA | Bladder Urothelial Carcinoma | NCH |
| 176 | THCA | Thyroid carcinoma | NCH |
| 177 | BRCA | Breast invasive carcinoma | NCH |
| 178 | UCEC | Uterine Corpus Endometrial Carcinoma | NCH |
| 179 | CESC | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
| 180 | SKCM | Skin Cutaneous Melanoma | NCH |
| 181 | LUSC | Lung squamous cell carcinoma | NCH |
| 182 | THCA | Thyroid carcinoma | NCH |
| 183 | LUAD | Lung adenocarcinoma | NCH |
| 184 | PRAD | Prostate adenocarcinoma | NCH |
| 185 | BRCA | Breast invasive carcinoma | NCH |
| 186 | UCEC | Uterine Corpus Endometrial Carcinoma | NCH |
| 187 | CESC | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
| 188 | HNSC | Head and Neck squamous cell carcinoma | NCH |
| 189 | LGG | Brain Lower Grade Glioma | NCH |
| 190 | HNSC | Head and Neck squamous cell carcinoma | NCH |
| 191 | THCA | Thyroid carcinoma | NCH |
| 192 | BLCA | Bladder Urothelial Carcinoma | NCH |
| 193 | LUSC | Lung squamous cell carcinoma | NCH |
| 194 | KIRP | Kidney renal papillary cell carcinoma | NCH |
| 195 | PAAD | Pancreatic adenocarcinoma | NCH |
| 196 | LUAD | Lung adenocarcinoma | NCH |
| 197 | THCA | Thyroid carcinoma | NCH |
| 198 | SKCM | Skin Cutaneous Melanoma | NCH |
| 199 | BLCA | Bladder Urothelial Carcinoma | NCH |
| 200 | CESC | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
| 201 | UCEC | Uterine Corpus Endometrial Carcinoma | NCH |
| 202 | BRCA | Breast invasive carcinoma | NCH |
| 203 | LIHC | Liver hepatocellular carcinoma | NCH |
| 204 | LUAD | Lung adenocarcinoma | NCH |
| 205 | THCA | Thyroid carcinoma | NCH |
| 206 | SKCM | Skin Cutaneous Melanoma | NCH |
| 207 | BLCA | Bladder Urothelial Carcinoma | NCH |
| 208 | LUSC | Lung squamous cell carcinoma | NCH |
| 209 | KIRP | Kidney renal papillary cell carcinoma | NCH |
| 210 | PAAD | Pancreatic adenocarcinoma | NCH |
| 211 | STAD | Stomach adenocarcinoma | NCH |
| 212 | DLBC | Lymphoid Neoplasm Diffuse Large B-cell Lymphoma | NCH |
| 213 | LUAD | Lung adenocarcinoma | NCH |
| 214 | LUSC | Lung squamous cell carcinoma | NCH |
| 215 | HNSC | Head and Neck squamous cell carcinoma | NCH |
| 216 | BRCA | Breast invasive carcinoma | NCH |
| 217 | CESC | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
| 218 | SARC | Sarcoma | NCH |
| 219 | LGG | Brain Lower Grade Glioma | NCH |
| 220 | STAD | Stomach adenocarcinoma | NCH |
| 221 | PRAD | Prostate adenocarcinoma | NCH |
| 222 | LUAD | Lung adenocarcinoma | NCH |
| 223 | BLCA | Bladder Urothelial Carcinoma | NCH |
| 224 | THCA | Thyroid carcinoma | NCH |
| 225 | LUSC | Lung squamous cell carcinoma | NCH |
| 226 | KICH | Kidney Chromophobe | NCH |
| 227 | BRCA | Breast invasive carcinoma | NCH |
| 228 | UCEC | Uterine Corpus Endometrial Carcinoma | NCH |
| 229 | SARC | Sarcoma | NCH |
| 230 | THCA | Thyroid carcinoma | NCH |
| 231 | LIHC | Liver hepatocellular carcinoma | NCH |
| 232 | LUAD | Lung adenocarcinoma | NCH |
| 233 | LUSC | Lung squamous cell carcinoma | NCH |
| 234 | BRCA | Breast invasive carcinoma | NCH |
| 235 | BLCA | Bladder Urothelial Carcinoma | NCH |
| 236 | CESC | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
| 237 | THCA | Thyroid carcinoma | NCH |
| 238 | LUAD | Lung adenocarcinoma | NCH |
| 239 | BRCA | Breast invasive carcinoma | NCH |
| 240 | SKCM | Skin Cutaneous Melanoma | NCH |
| 241 | HNSC | Head and Neck squamous cell carcinoma | NCH |
| 242 | STAD | Stomach adenocarcinoma | NCH |
| 243 | LUSC | Lung squamous cell carcinoma | NCH |
| 244 | PRAD | Prostate adenocarcinoma | NCH |
| 245 | LGG | Brain Lower Grade Glioma | NCH |
| 246 | KIRP | Kidney renal papillary cell carcinoma | NCH |
| 247 | PAAD | Pancreatic adenocarcinoma | NCH |
| 248 | DLBC | Lymphoid Neoplasm Diffuse Large B-cell Lymphoma | NCH |
| 249 | BLCA | Bladder Urothelial Carcinoma | NCH |
| 250 | THCA | Thyroid carcinoma | NCH |
| 251 | KICH | Kidney Chromophobe | NCH |
| 252 | BLCA | Bladder Urothelial Carcinoma | NCH |
| 253 | THCA | Thyroid carcinoma | NCH |
| 254 | ESCA | Esophageal carcinoma | NCH |
| 255 | BRCA | Breast invasive carcinoma | NCH |
| 256 | CESC | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
| 257 | STAD | Stomach adenocarcinoma | NCH |
| 258 | LUAD | Lung adenocarcinoma | NCH |
| 259 | LUSC | Lung squamous cell carcinoma | NCH |
| 260 | HNSC | Head and Neck squamous cell carcinoma | NCH |
| 261 | KIRP | Kidney renal papillary cell carcinoma | NCH |
| 262 | SKCM | Skin Cutaneous Melanoma | NCH |
| 263 | SARC | Sarcoma | NCH |
| 264 | LUAD | Lung adenocarcinoma | NCH |
| 265 | HNSC | Head and Neck squamous cell carcinoma | NCH |
| 266 | KIRP | Kidney renal papillary cell carcinoma | NCH |
| 267 | LUSC | Lung squamous cell carcinoma | NCH |
| 268 | PRAD | Prostate adenocarcinoma | NCH |
| 269 | STAD | Stomach adenocarcinoma | NCH |
| 270 | THCA | Thyroid carcinoma | NCH |
| 271 | BRCA | Breast invasive carcinoma | NCH |
| 272 | ESCA | Esophageal carcinoma | NCH |
| 273 | HNSC | Head and Neck squamous cell carcinoma | NCH |
| 274 | KIRC | Kidney renal clear cell carcinoma | NCH |
| 275 | LIHC | Liver hepatocellular carcinoma | NCH |
| 276 | LUSC | Lung squamous cell carcinoma | NCH |
| 277 | SKCM | Skin Cutaneous Melanoma | NCH |
| 278 | LUAD | Lung adenocarcinoma | NCH |
| 279 | BLCA | Bladder Urothelial Carcinoma | NCH |
| 280 | CESC | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
| 281 | KIRP | Kidney renal papillary cell carcinoma | NCH |
| 282 | LGG | Brain Lower Grade Glioma | NCH |
| 283 | LUSC | Lung squamous cell carcinoma | NCH |
| 284 | PAAD | Pancreatic adenocarcinoma | NCH |
| 285 | PRAD | Prostate adenocarcinoma | NCH |
| 286 | SARC | Sarcoma | NCH |
| 287 | LIHC | Liver hepatocellular carcinoma | NCH |
| 288 | BRCA | Breast invasive carcinoma | NCH |
| 289 | UCEC | Uterine Corpus Endometrial Carcinoma | NCH |
| 290 | SARC | Sarcoma | NCH |
| 291 | SKCM | Skin Cutaneous Melanoma | NCH |
| 292 | LGG | Brain Lower Grade Glioma | NCH |
| 293 | LUSC | Lung squamous cell carcinoma | NCH |
| 294 | BLCA | Bladder Urothelial Carcinoma | NCH |
| 295 | LGG | Brain Lower Grade Glioma | NCH |
| 296 | BRCA | Breast invasive carcinoma | NCH |
| 297 | CESC | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
| 298 | ESCA | Esophageal carcinoma | NCH |
| 299 | KIRP | Kidney renal papillary cell carcinoma | NCH |
| 300 | COAD | Colon adenocarcinoma | NCH |
| 301 | HNSC | Head and Neck squamous cell carcinoma | NCH |
| 302 | UCS | Uterine Carcinosarcoma | NCH |
| 303 | LIHC | Liver hepatocellular carcinoma | NCH |
| 304 | ACC | Adrenocortical carcinoma | NCH |
| 305 | BRCA | Breast invasive carcinoma | NCH |
| 306 | LGG | Brain Lower Grade Glioma | NCH |
| 307 | SARC | Sarcoma | NCH |
| 308 | PRAD | Prostate adenocarcinoma | NCH |
| 309 | BLCA | Bladder Urothelial Carcinoma | NCH |
| 310 | SARC | Sarcoma | NCH |
| 311 | HNSC | Head and Neck squamous cell carcinoma | NCH |
| 312 | PRAD | Prostate adenocarcinoma | NCH |
| 313 | ACC | Adrenocortical carcinoma | NCH |
| 314 | LIHC | Liver hepatocellular carcinoma | NCH |
| 315 | PRAD | Prostate adenocarcinoma | NCH |
| 316 | SKCM | Skin Cutaneous Melanoma | NCH |
| 317 | BLCA | Bladder Urothelial Carcinoma | NCH |
| 318 | HNSC | Head and Neck squamous cell carcinoma | NCH |
| 319 | LGG | Brain Lower Grade Glioma | NCH |
| 320 | PRAD | Prostate adenocarcinoma | NCH |
| 321 | STAD | Stomach adenocarcinoma | NCH |
| 322 | BRCA | Breast invasive carcinoma | NCH |
| 323 | ESCA | Esophageal carcinoma | NCH |
| 324 | UCEC | Uterine Corpus Endometrial Carcinoma | NCH |
| 325 | KIRP | Kidney renal papillary cell carcinoma | NCH |
| 326 | DLBC | Lymphoid Neoplasm Diffuse Large B-cell Lymphoma | NCH |
| 327 | LIHC | Liver hepatocellular carcinoma | NCH |
| 328 | BLCA | Bladder Urothelial Carcinoma | NCH |
| 329 | LGG | Brain Lower Grade Glioma | NCH |
| 330 | PAAD | Pancreatic adenocarcinoma | NCH |
| 331 | PRAD | Prostate adenocarcinoma | NCH |
| 332 | SKCM | Skin Cutaneous Melanoma | NCH |
| 333 | STAD | Stomach adenocarcinoma | NCH |
| 334 | BRCA | Breast invasive carcinoma | NCH |
| 335 | CESC | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
| 336 | SARC | Sarcoma | NCH |
| 337 | BLCA | Bladder Urothelial Carcinoma | NCH |
| 338 | BRCA | Breast invasive carcinoma | NCH |
| 339 | ESCA | Esophageal carcinoma | NCH |
| 340 | KIRC | Kidney renal clear cell carcinoma | NCH |
| 341 | LIHC | Liver hepatocellular carcinoma | NCH |
| 342 | SARC | Sarcoma | NCH |
| 343 | STAD | Stomach adenocarcinoma | NCH |
| 344 | KIRP | Kidney renal papillary cell carcinoma | NCH |
| 345 | LIHC | Liver hepatocellular carcinoma | NCH |
| 346 | GBM | Glioblastoma multiforme | NCH |
| 347 | LGG | Brain Lower Grade Glioma | NCH |
| 348 | PRAD | Prostate adenocarcinoma | NCH |
| 349 | PAAD | Pancreatic adenocarcinoma | NCH |
| 350 | CESC | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
| 351 | KICH | Kidney Chromophobe | NCH |
| 352 | LGG | Brain Lower Grade Glioma | NCH |
| 353 | MESO | Mesothelioma | NCH |
| 354 | UCEC | Uterine Corpus Endometrial Carcinoma | NCH |
| 355 | HNSC | Head and Neck squamous cell carcinoma | NCH |
| 356 | BLCA | Bladder Urothelial Carcinoma | NCH |
| 357 | PRAD | Prostate adenocarcinoma | NCH |
| 358 | SKCM | Skin Cutaneous Melanoma | NCH |
| 359 | STAD | Stomach adenocarcinoma | NCH |
| 360 | BRCA | Breast invasive carcinoma | NCH |
| 361 | CESC | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
| 362 | ESCA | Esophageal carcinoma | NCH |
| 363 | SARC | Sarcoma | NCH |
| 364 | KIRP | Kidney renal papillary cell carcinoma | NCH |
| 365 | LIHC | Liver hepatocellular carcinoma | NCH |
| 366 | PCPG | Pheochromocytoma and Paraganglioma | NCH |
| 367 | BLCA | Bladder Urothelial Carcinoma | NCH |
| 368 | LGG | Brain Lower Grade Glioma | NCH |
| 369 | PAAD | Pancreatic adenocarcinoma | NCH |
| 370 | PRAD | Prostate adenocarcinoma | NCH |
| 371 | STAD | Stomach adenocarcinoma | NCH |
| 372 | BRCA | Breast invasive carcinoma | NCH |
| 373 | CESC | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
| 374 | ESCA | Esophageal carcinoma | NCH |
| 375 | SARC | Sarcoma | NCH |
| 376 | KIRP | Kidney renal papillary cell carcinoma | NCH |
| 377 | LIHC | Liver hepatocellular carcinoma | NCH |
| 378 | GBM | Glioblastoma multiforme | NCH |
| 379 | BRCA | Breast invasive carcinoma | NCH |
| 380 | CESC | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
| 381 | UCEC | Uterine Corpus Endometrial Carcinoma | NCH |
| 382 | ESCA | Esophageal carcinoma | NCH |
| 383 | SARC | Sarcoma | NCH |
| 384 | LIHC | Liver hepatocellular carcinoma | NCH |
| 385 | COAD | Colon adenocarcinoma | NCH |
| 386 | KIRP | Kidney renal papillary cell carcinoma | NCH |
| 387 | KIRC | Kidney renal clear cell carcinoma | NCH |
| 388 | SKCM | Skin Cutaneous Melanoma | NCH |
| 389 | PRAD | Prostate adenocarcinoma | NCH |
| 390 | PAAD | Pancreatic adenocarcinoma | NCH |
| 391 | BLCA | Bladder Urothelial Carcinoma | NCH |
| 392 | PAAD | Pancreatic adenocarcinoma | NCH |
| 393 | SKCM | Skin Cutaneous Melanoma | NCH |
| 394 | CESC | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
| 395 | ESCA | Esophageal carcinoma | NCH |
| 396 | SARC | Sarcoma | NCH |
| 397 | DLBC | Lymphoid Neoplasm Diffuse Large B-cell Lymphoma | NCH |
| 398 | KIRP | Kidney renal papillary cell carcinoma | NCH |
| 399 | LIHC | Liver hepatocellular carcinoma | NCH |
| 401 | BLCA | Bladder Urothelial Carcinoma | NCH |
| 402 | GBM | Glioblastoma multiforme | NCH |
| 403 | HNSC | Head and Neck squamous cell carcinoma | NCH |
| 404 | KIRC | Kidney renal clear cell carcinoma | NCH |
| 405 | LIHC | Liver hepatocellular carcinoma | NCH |
| 406 | LUAD | Lung adenocarcinoma | NCH |
| 407 | DLBC | Lymphoid Neoplasm Diffuse Large B-cell Lymphoma | NCH |
| 408 | SKCM | Skin Cutaneous Melanoma | NCH |
| 409 | OV | Ovarian serous cystadenocarcinoma | NCH |
| 410 | PAAD | Pancreatic adenocarcinoma | NCH |
| 411 | READ | Rectum adenocarcinoma | NCH |
| 412 | SARC | Sarcoma | NCH |
| 413 | STAD | Stomach adenocarcinoma | NCH |
| 414 | THCA | Thyroid carcinoma | NCH |
| 415 | LUSC | Lung squamous cell carcinoma | NCH |
| 416 | SKCM | Skin Cutaneous Melanoma | NCH |
| 417 | UVM | Uveal Melanoma | NCH |
| 418 | MESO | Mesothelioma | NCH |
| 419 | ESCA | Esophageal carcinoma | NCH |
| 420 | CESC | Cervical squamous cell carcinoma and endocervical adenocarcinoma | NCH |
| 421 | UCEC | Uterine Corpus Endometrial Carcinoma | NCH |
| 422 | COAD | Colon adenocarcinoma | NCH |
| 423 | LUAD | Lung adenocarcinoma | NCH |
| 424 | PAAD | Pancreatic adenocarcinoma | NCH |
| 425 | LIHC | Liver hepatocellular carcinoma | NCH |
| 426 | SARC | Sarcoma | NCH |
| 427 | STAD | Stomach adenocarcinoma | NCH |
| 428 | CHOL | Cholangiocarcinoma | NCH |
| 429 | PRAD | Prostate adenocarcinoma | NCH |
| 430 | TGCT | Testicular Germ Cell Tumors | NCH |
| 431 | THYM | Thymoma | NCH |
| 432 | KIRP | Kidney renal papillary cell carcinoma | NCH |
| 433 | BLCA | Bladder Urothelial Carcinoma | NCH |
| 434 | PAAD | Pancreatic adenocarcinoma | NCH |
| 448 | CHOL | Cholangiocarcinoma | NCH |
| 458 | LCML | Chronic Myelogenous Leukemia | NCH |
